metaLead Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.21M
- Investors
-
7
metaLead General Information
Description
Developer of peptide-based therapeutics designed to treat metal-related diseases and toxic metal accumulation disorders. The company develops selective metal-binding therapies and chelation treatments for conditions such as Wilson disease and lead poisoning, enabling healthcare providers to remove toxic metals while preserving essential metals and improving patient outcomes.
Contact Information
Website
www.metalead.chCorporate Office
- Hochbergerstrasse 60C
- 4057 Basel
- Switzerland
Corporate Office
- Hochbergerstrasse 60C
- 4057 Basel
- Switzerland
metaLead Timeline
metaLead Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Early Stage VC | 18-May-2025 | $1.21M | Completed | Pre-Clinical Trials | ||
| 8. Accelerator/Incubator | 03-Dec-2024 | Completed | Pre-Clinical Trials | |||
| 7. Accelerator/Incubator | 01-Oct-2024 | Completed | Pre-Clinical Trials | |||
| 6. Accelerator/Incubator | 31-Aug-2023 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 10-Mar-2023 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 15-Feb-2023 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 10-May-2022 | $10.4K | Completed | Pre-Clinical Trials | ||
| 1. University Spin-Out | 01-Jan-2022 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
metaLead Signals
metaLead Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| UZH Lifesciences Fund | Venture Capital | Minority | ||
| Kickfund | Venture Capital | Minority | ||
| BaseLaunch | Accelerator/Incubator | |||
| BioInnovation Institute | Accelerator/Incubator | |||
| Venture (Switzerland) | Accelerator/Incubator | Minority |
metaLead FAQs
-
When was metaLead founded?
metaLead was founded in 2022.
-
Where is metaLead headquartered?
metaLead is headquartered in Basel, Switzerland.
-
What is the size of metaLead?
metaLead has 5 total employees.
-
What industry is metaLead in?
metaLead’s primary industry is Drug Discovery.
-
Is metaLead a private or public company?
metaLead is a Private company.
-
What is metaLead’s current revenue?
The current revenue for metaLead is .
-
How much funding has metaLead raised over time?
metaLead has raised $3.02M.
-
Who are metaLead’s investors?
UZH Lifesciences Fund, Kickfund, BaseLaunch, BioInnovation Institute, and Venture (Switzerland) are 5 of 7 investors who have invested in metaLead.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process